期刊文献+

癌痛患者药学监护模式的探讨 被引量:3

Investigation about the patterns of pharmaceutical care for cancer pain patients
下载PDF
导出
摘要 目的探讨癌痛患者药学监护的模式与效果。方法采用WHO合理用药调研方法,通过了解和分析癌痛患者药物治疗的情况及其中存在的问题,提出药物治疗建议,制订个体化药学监护计划,实施全程药学监护。结果50例癌痛患者的疼痛评分(NRS)由(4.9±1.6)分降低为(1.7±0.7),较干预前降低,差异有高度统计学意义(P<0.01);50例患者用药依从性与药学监护前相比有显著提高,差异有高度统计学意义(P<0.01);药物不良反应改善。结论临床药师参与癌痛控制,可减轻患者癌痛,提高用药依从性,改善药物不良反应。 Objective To investigate the pattern and effect of pharmaceutical care for cancer pain patients. Methods The investigation was carried out by using the researching methods of WHO rational drug use. Through understanding and analyzing the situation and problem in drug therapy for cancer pain patients, forward suggestion was putted by clinical pharmacists, individualized pharmaceutical care plan was developed and total pharmaceutical care was actualized. Results The NRS scores of 50 cases of patients with cancer pain was decreased from(4.9±1.6) scores to(1.7±0.7)scores, which was significantly lower than that before intervention(P〈0.01). The compliance with medication of 50cases of patients was greatly improved comparing with that before pharmaceutical care(P〈0.01). The adverse drug reactions was improved. Conclusion Clinical pharmacists participating in the control of cancer pain can reduce the cancer pain of patients, improve compliance with medication and adverse drug reactions.
出处 《中国医药导报》 CAS 2014年第21期135-138,共4页 China Medical Herald
基金 广东省肇庆市科技创新计划项目(编号2013E258)
关键词 癌痛 临床药师 药学监护 Pain Clinical pharmacists Pharmaceutical care
  • 相关文献

参考文献15

二级参考文献61

  • 1周玉美,曾琴琴.肿瘤病人便秘的原因分析及护理[J].当代护士(中旬刊),2004,11(10):55-57. 被引量:6
  • 2徐国柱,蔡志基.镇痛药临床评价方法研究[J].中国新药杂志,1995,4(4):20-22. 被引量:256
  • 3赵继军,周玲君,宋莉娟,邱彩锋.上海市医护人员癌痛认知状况调查及对策[J].中华护理杂志,2007,42(2):162-165. 被引量:54
  • 4Mercadante S ,Fulfaro F. Wodcl Health Organization guidelines for cancer pain :a reappraisal [ J ]. Ann Oncol, 2005,16 ( Suppl 4) :iv132-iv135.
  • 5Mandema JW, Kaiko RF, Oshlack B, et al. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone[J]. Br J Clin Pharmacol,1996,42(6) :747-756.
  • 6Cpeter NW,Dwight M, Judith WW. Controlle-release oxycodone relieves ncuropathic pain: a randomized controlled trial in painful diabetic neuropathy[ J]. Pain,2003,105:71-78.
  • 7Ackerman S J, Mordin M. Patient-reported utilization patterns of system and oxycodone hydroehloride controlled-release among patients with chronic nonmalignant pain [ J ]. Manag Care pharm ,2003,9 ( 3 ) : 223-231.
  • 8Anonymous. NCCN clinical practice guidelines in oncology-colon cancer guideline [OL]. 2011. http://www.nccn.org/professionals/physiciangls/PDF/ colon.pdf.
  • 9Schrijvers D. Pain control in cancer: recent findings and trends [J]. Ann Oncol,2007,18(9):37-42.
  • 10Breitbart W, Chandler S, Eagel B, et al. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain [J]. Oncology, 2000,14:695 -702.

共引文献250

同被引文献37

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部